These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23483999)

  • 1. Aggregation of human S100A8 and S100A9 amyloidogenic proteins perturbs proteostasis in a yeast model.
    Eremenko E; Ben-Zvi A; Morozova-Roche LA; Raveh D
    PLoS One; 2013; 8(3):e58218. PubMed ID: 23483999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro-inflammatory S100A8 and S100A9 proteins: self-assembly into multifunctional native and amyloid complexes.
    Vogl T; Gharibyan AL; Morozova-Roche LA
    Int J Mol Sci; 2012; 13(3):2893-2917. PubMed ID: 22489132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium-dependent tetramer formation of S100A8 and S100A9 is essential for biological activity.
    Leukert N; Vogl T; Strupat K; Reichelt R; Sorg C; Roth J
    J Mol Biol; 2006 Jun; 359(4):961-72. PubMed ID: 16690079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid formation by the pro-inflammatory S100A8/A9 proteins in the ageing prostate.
    Yanamandra K; Alexeyev O; Zamotin V; Srivastava V; Shchukarev A; Brorsson AC; Tartaglia GG; Vogl T; Kayed R; Wingsle G; Olsson J; Dobson CM; Bergh A; Elgh F; Morozova-Roche LA
    PLoS One; 2009; 4(5):e5562. PubMed ID: 19440546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antimicrobial heterodimer S100A8/S100A9 (calprotectin) is upregulated by bacterial flagellin in human epidermal keratinocytes.
    Abtin A; Eckhart L; Gläser R; Gmeiner R; Mildner M; Tschachler E
    J Invest Dermatol; 2010 Oct; 130(10):2423-30. PubMed ID: 20555353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100A8 and S100A9 are associated with colorectal carcinoma progression and contribute to colorectal carcinoma cell survival and migration via Wnt/β-catenin pathway.
    Duan L; Wu R; Ye L; Wang H; Yang X; Zhang Y; Chen X; Zuo G; Zhang Y; Weng Y; Luo J; Tang M; Shi Q; He T; Zhou L
    PLoS One; 2013; 8(4):e62092. PubMed ID: 23637971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells.
    Hermani A; De Servi B; Medunjanin S; Tessier PA; Mayer D
    Exp Cell Res; 2006 Jan; 312(2):184-97. PubMed ID: 16297907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of calcium-binding proteins, S100A8 and S100A9, in invasive phenotype of human gastric cancer cells.
    Yong HY; Moon A
    Arch Pharm Res; 2007 Jan; 30(1):75-81. PubMed ID: 17328245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis of the complex formation between the two calcium-binding proteins S100A8 (MRP8) and S100A9 (MRP14).
    Leukert N; Sorg C; Roth J
    Biol Chem; 2005 May; 386(5):429-34. PubMed ID: 15927886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S100A8 and S100A9, both transcriptionally regulated by PU.1, promote epithelial-mesenchymal transformation (EMT) and invasive growth of dermal keratinocytes during scar formation post burn.
    Xu Z; Cheng C; Kong R; Liu Y; Wang S; Ma Y; Xing X
    Aging (Albany NY); 2021 Jun; 13(11):15523-15537. PubMed ID: 34099591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100A9 induces differentiation of acute myeloid leukemia cells through TLR4.
    Laouedj M; Tardif MR; Gil L; Raquil MA; Lachhab A; Pelletier M; Tessier PA; Barabé F
    Blood; 2017 Apr; 129(14):1980-1990. PubMed ID: 28137827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autocrine pathways involving S100A8 and/or S100A9 that are postulated to regulate the immunological functions of macrophages in rats.
    Okada K; Arai S; Nakase H; Kohno H; Nakamura F; Takeda M; Toda Y; Itoh H; Adachi S; Ikemoto M
    Biochem Biophys Res Commun; 2015 Jan; 456(1):415-20. PubMed ID: 25485702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia and HIF-1 increase S100A8 and S100A9 expression in prostate cancer.
    Grebhardt S; Veltkamp C; Ströbel P; Mayer D
    Int J Cancer; 2012 Dec; 131(12):2785-94. PubMed ID: 22505354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active involvement of alarmins S100A8 and S100A9 in the regulation of synovial activation and joint destruction during mouse and human osteoarthritis.
    van Lent PL; Blom AB; Schelbergen RF; Slöetjes A; Lafeber FP; Lems WF; Cats H; Vogl T; Roth J; van den Berg WB
    Arthritis Rheum; 2012 May; 64(5):1466-76. PubMed ID: 22143922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular expression of inflammatory proteins S100A8 and S100A9 leads to epithelial-mesenchymal transition and attenuated aggressivity of breast cancer cells.
    Cormier K; Harquail J; Ouellette RJ; Tessier PA; Guerrette R; Robichaud GA
    Anticancer Agents Med Chem; 2014 Jan; 14(1):35-45. PubMed ID: 24041228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100A8 and S100A9 proteins form part of a paracrine feedback loop between pancreatic cancer cells and monocytes.
    Nedjadi T; Evans A; Sheikh A; Barerra L; Al-Ghamdi S; Oldfield L; Greenhalf W; Neoptolemos JP; Costello E
    BMC Cancer; 2018 Dec; 18(1):1255. PubMed ID: 30558665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alarmins S100A8 and S100A9 elicit a catabolic effect in human osteoarthritic chondrocytes that is dependent on Toll-like receptor 4.
    Schelbergen RF; Blom AB; van den Bosch MH; Slöetjes A; Abdollahi-Roodsaz S; Schreurs BW; Mort JS; Vogl T; Roth J; van den Berg WB; van Lent PL
    Arthritis Rheum; 2012 May; 64(5):1477-87. PubMed ID: 22127564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100A8 and S100A9 in human arterial wall. Implications for atherogenesis.
    McCormick MM; Rahimi F; Bobryshev YV; Gaus K; Zreiqat H; Cai H; Lord RS; Geczy CL
    J Biol Chem; 2005 Dec; 280(50):41521-9. PubMed ID: 16216873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular interface of S100A8 with cytochrome b558 and NADPH oxidase activation.
    Berthier S; Nguyen MV; Baillet A; Hograindleur MA; Paclet MH; Polack B; Morel F
    PLoS One; 2012; 7(7):e40277. PubMed ID: 22808130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of
    Defrêne J; Berrazouane S; Esparza N; Pagé N; Côté MF; Gobeil S; Aoudjit F; Tessier PA
    J Immunol; 2021 Feb; 206(3):505-514. PubMed ID: 33361205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.